January 4, 2018......FutureLand Corp (OTCMKTS:FUTL) issued a shareholder letters updating them on recent accomplishments and business growth. The company acquired 20% of Apotheca Biosciences, LLC, which is a cannabinoid pharma firm that is set to breakout, from CB Scientific earlier this year. This acquired firm is currently in discussions with another public firm who has shown an interest to acquire them early next year. If this materializes, their position in the firm could be substantial.
The details
FutureLand also bought Bitcoin Labs, LLC in the year. The firm is assessing a blockchain raise with its cryptocurrency named LandCoin to allow the firm to make numerous major deals that have already been planned during this last year. This is probably to take number months to get together, however the timing could not get better given investors’ interest toward crypto. Ethereum, Dash, Litecoin and Bitcoin, to mention a few are surpassing expectations.
FutureLand has also proposed letters of intent to buy other firms that are still pending mutual deal in order to move forward. Once they close a deal, they will make sure that the company’s shareholders are the first ones to get updates.
To summarize, FutureLand recorded an amazing year pertaining to company’s revenue and business growth, however they have had their issues also like share depreciation; unrelated to their business development and overall business growth. Next year, they project to overcome previous issues and expand on their successes to validate their business model and enhance shareholder value.
In the last trading session, the shares price of FutureLand moved in either direction only to close flat at $0.0006. The traded share volume was 91.66 million compared to average share volume of 129 million. In the last five trading sessions, the stock has posted gains of over 20%, however for the year the stock is down over 95%.
PennyStks are like roses, you got ta
look out for the pricks...
